Cholangiopathy as part of post-COVID syndrome

Manuel Rojas; Yhojan Rodríguez; Elizabeth Zapata; Juan Carlos Hernández; Juan Manuel Anaya

doi:10.1016/j.jtauto.2021.100116

Cholangiopathy as part of post-COVID syndrome

Manuel Rojas, Yhojan Rodríguez, Elizabeth Zapata, Juan Carlos Hernández, Juan Manuel Anaya

School of Medicine and Health Sciences

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

Original language	English
Article number	100116
Journal	Journal of Translational Autoimmunity
Volume	4
DOIs	https://doi.org/10.1016/j.jtauto.2021.100116
Publication status	Published - Jan 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors

ASJC Scopus Subject Areas

Immunology and Allergy
Immunology

Keywords

COVID-19
Cholangiopathy
Hepatopathy
Post-COVID syndrome

Access to Document

10.1016/j.jtauto.2021.100116

Cite this

@article{0d849869aa5f46b3b725865735186d31,

title = "Cholangiopathy as part of post-COVID syndrome",

abstract = "Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.",

keywords = "COVID-19, Cholangiopathy, Hepatopathy, Post-COVID syndrome",

author = "Manuel Rojas and Yhojan Rodr{\'i}guez and Elizabeth Zapata and Hern{\'a}ndez, {Juan Carlos} and Anaya, {Juan Manuel}",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors",

year = "2021",

month = jan,

doi = "10.1016/j.jtauto.2021.100116",

language = "English",

volume = "4",

journal = "Journal of Translational Autoimmunity",

issn = "2589-9090",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cholangiopathy as part of post-COVID syndrome

AU - Rojas, Manuel

AU - Rodríguez, Yhojan

AU - Zapata, Elizabeth

AU - Hernández, Juan Carlos

AU - Anaya, Juan Manuel

PY - 2021/1

Y1 - 2021/1

N2 - Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

AB - Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

KW - COVID-19

KW - Cholangiopathy

KW - Hepatopathy

KW - Post-COVID syndrome

UR - http://www.scopus.com/inward/record.url?scp=85122728446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122728446&partnerID=8YFLogxK

U2 - 10.1016/j.jtauto.2021.100116

DO - 10.1016/j.jtauto.2021.100116

M3 - Article

AN - SCOPUS:85122728446

SN - 2589-9090

VL - 4

JO - Journal of Translational Autoimmunity

JF - Journal of Translational Autoimmunity

M1 - 100116

ER -

Cholangiopathy as part of post-COVID syndrome

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this